Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Monoclonal Antibody

Anti-Human HB/Hemoglobin Monoclonal Antibody (1A312)

Catalog #:   MHF62901 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG
Applications: GICA, IFA, TIA
Overview

Catalog No.

MHF62901

Species reactivity

Human

Host species

Mouse

Isotype

IgG

Clonality

Monoclonal

Immunogen

Human HB/Hemoglobin Protein.

Target

Hemoglobin subunit beta, Beta-globin, Hemoglobin beta chain, LVV-hemorphin-7, Spinorphin, HBB

Concentration

1mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Applications

GICA, IFA, TIA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

1A312

Data Image
References

Serological analysis of gluten-related antibodies in idiopathic neuropathies and cerebellar ataxia., PMID:40481865

Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study., PMID:40473445

TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study., PMID:40436854

Characterization and Specific Detection of Lactobacillus paracasei-Derived Extracellular Vesicles Using Anti-p40-Modified Au Thin Film., PMID:40430944

Cognitive Impairment in ANCA-Associated Vasculitis: A Cross-Sectional Pilot Study., PMID:40429578

Animal Models in Rheumatoid Arthritis: Is There a Correlation Between Autoantibodies in Human Pathology and Animal Models?, PMID:40427650

Last Resort? Rationale for Comprehensive Molecular Analysis in Treatment-Refractory R/M HNSCC: A Case Report of Remarkable Response to Sacituzumab Govitecan Following Molecular and Functional Characterization., PMID:40427091

Characterizing local antibody responses in the muscle of inclusion body myositis patients., PMID:40424896

A Rare Case of Severe Pernicious Anemia with Neuropsychiatric Implications., PMID:40413579

Receptor-mediated transcytosis of nanobodies targeting the heparin-binding EGF-like growth factor in human blood-brain barrier models., PMID:40393531

Design and Pharmacological Characterization of a Novel Antithrombotic P2Y1 Receptor-Based Vaccine., PMID:40362620

The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab., PMID:40347721

Teclistamab Dosing in Responders: Modeling and Simulation Results from the MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma., PMID:40332715

P-Selectin, Vascular Endothelial Cadherin, and Vascular Cell Adhesion Molecule-1 as Novel Biomarkers for ABO Hemolytic Disease of the Fetus and Newborn., PMID:40331036

Wearable Photonic Device for Multiple Biomarker Sampling and Detection without Blood Draws., PMID:40326959

Preclinical therapeutics for sickle cell disease: modern developments and future considerations., PMID:40323290

Longstanding, undiagnosed, highly replicative hepatitis B virus reactivation in the presence of high levels of anti-HBs antibodies., PMID:40319465

Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine., PMID:40298376

Automated and virus variant-programmable surrogate test qualitatively compares to the gold standard SARS-CoV-2 neutralization assay., PMID:40295688

Inactivated Viral Vaccine BBV87 Protects Against Chikungunya Virus Challenge in a Non-Human Primate Model., PMID:40284993

Correlation of Inflammatory Biomarkers and IgG4 Antibodies with Malaria in Cameroon's Buea Municipality Children., PMID:40277833

Cyclosporine A Combined with Rituximab Successfully Treated Erythropoietin-Induced Pure Red Blood Cell Aplastic Anemia., PMID:40276465

Macrophage-Tased Dual-Phase T Cell Immunomodulation to Combat Transplant Rejection., PMID:40264278

Association between drug-related cutaneous adverse events and survival outcomes in patients treated with enfortumab vedotin., PMID:40252634

Treatment and clinical outcomes of pediatric autoimmune hemolytic anemia: real-world single-center data from Korea., PMID:40241594

Nanobody Engineered and Photosensitiser Loaded Bacterial Outer Membrane Vesicles Potentiate Antitumour Immunity and Immunotherapy., PMID:40240911

Paediatric autoimmune uveitis is associated with intraocular antibodies against Epstein-Barr virus Nuclear Antigen 1 (EBNA-1)., PMID:40239467

Anemia, hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell antibody positivity in oral lichen planus patients with vitamin B12 deficiency., PMID:40224072

Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in oral lichen planus patients with iron deficiency., PMID:40224068

Delayed Hepatitis B Virus Reactivation at 33 Months after the Completion of Rituximab-based Chemotherapy., PMID:40222940

A replicating RNA vaccine confers protection against Crimean-Congo hemorrhagic fever in cynomolgus macaques., PMID:40222105

Maternal exposure to per- and polyfluoroalkyl substances and epitope level antibody response to vaccines against measles and rubella in children from the Boston birth cohort., PMID:40215916

Development and evaluation of ELISA serological immunoassays for influenza and respiratory syncytial viruses., PMID:40215609

Exploring Protein A Immunoadsorption for Autoimmune Hemolytic Anemia with Hyper-IgG4emia., PMID:40211490

Hepatitis B virus infection after immunization: How serious it is? An updated review., PMID:40210771

Hepatitis B Vaccine Nonresponse and Associated Risk Factors: Insights From a Cohort Study., PMID:40181820

Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar., PMID:40175862

An mRNA-based seasonal influenza vaccine in adults: Results of two phase 3 randomized clinical trials and correlate of protection analysis of hemagglutination inhibition titers., PMID:40174609

Targeting the tumour cell surface in advanced prostate cancer., PMID:40169837

Concizumab prophylaxis in people with hemophilia A or B without inhibitors: patient-reported outcome results from the phase 3 explorer8 study., PMID:40166710

Infectious Complications in Patients Treated with T-cell Engagers as Cancer Immunotherapies, A Descriptive Study from the REISAMIC Registry., PMID:40165410

RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques., PMID:40159504

Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S., PMID:40154791

Recent Advancements in Lung Cancer Metastasis Prevention Based on Nanostrategies., PMID:40135802

Whole-body visualization of SARS-CoV-2 biodistribution in vivo by immunoPET imaging in non-human primates., PMID:40118860

Navigating transfusion challenges: Bombay blood group in focus., PMID:40104353

Correlation between hepatitis B surface antibody (anti-HBs) in maternal blood and cord blood in newborn: a study on transplacental acquired maternal antibody., PMID:40102765

Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature., PMID:40034005

Role of PLA2R domain antibodies and epitope spreading in risk stratification and prediction of proteinuria remission in primary membranous nephropathy., PMID:40011527

Model-informed development of a cost-saving dosing regimen for enfortumab vedotin., PMID:39998586

Datasheet
$ 196
Product specifications
50 μg 196 100 μg 313

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human HB/Hemoglobin Monoclonal Antibody (1A312) [MHF62901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only